Recruiting studies: Major Depressive Disorder Recurrent

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway
NA · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT05913960 Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
Phase 4 · 1 location(s) · University of Texas at Austin · NCT05892744 Mechanisms of Rumination Change in Adolescent Depression
NA · 3 location(s) · Ohio State University · NCT03859297 Predictors of Relapse in Major Depressive Disorder (PERFORM-D)
Phase N/A · 9 location(s) · Abraham Nunes · NCT06746155 A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression
NA · 1 location(s) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksber · NCT06005103 Neurobiological and Genomic Predictors of Relapse in Depression
Phase N/A · 1 location(s) · Mehmet Kemal Arikan · NCT07328373 Psilocybin rTMS for Treatment Resistant Depression
Phase 2 · 1 location(s) · University of Texas at Austin · NCT06132178 Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study
NA · 1 location(s) · University of British Columbia · NCT05423275 Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression
Phase N/A · 1 location(s) · Max-Planck-Institute of Psychiatry · NCT06396312

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.